Le 14 novembre prochain aura lieu la #JournéeMondialeduDiabète .
L'occasion de rappeler qu'avant la découverte de l' #insuline en 1921, la vie des personnes vivant avec un #diabète était écourtée. Cette molécule change la vie de millions de patients chaque jour à travers le monde.

#Diabetes is a complex chronic condition, which is the root cause of many other #NCDs . Diabetes-related complications account for 3/4 of diabetes costs in #Europe . 💰 Many can be delayed +/ prevented with adequate #access .

We #needtoact NOW on a new #Diabetes Resolution! ⏰

32M people in the #EU live with #diabetes and more are on their way to developing it. We need more EU concerted #policy action to implement comprehensive diabetes #prevention as well as access to care and education. We need a new #DiabetesResolution NOW! ⏰

Lilly has spent over 30 years researching #Alzheimer ’s. Timely and accurate clinical diagnosis can give patients a better chance to benefit from treatments and help families plan for the future. Sirpa Pietikäinen🇫🇮🇪🇺 Deirdre Clune ADI Read more: e.lilly/3mnMCXc

La #diabetes tipo 2 es una enfermedad silente. Sin un control estricto desde sus inicios puede generar complicaciones a largo plazo, con el consiguiente coste social.
Descárgate el informe de @fundacionweber SED Diabetes Sociedad SEEN Federación Española de Diabetes (FEDE)
e.lilly/3WzStcW

Strong and predictable IP Rights are key if Europe is to be a location of choice for future medical innovation. Why does it matter for patients, health care systems and jobs?
e.lilly/3xFkHZK
@EUpatientsforum Internal Market, Industry, Entrepreneurship & SMEs

20 years ago, the amount of #investment made by pharmaceutical companies in R&D in 🇺🇸 and 🇪🇺 differed by €2 billion; in 2020, the difference had increased to €25 billion. Read more about how we can catch up: bit.ly/3WzWv4S
#WeWontRest

#BehindTheScenesWithDiabetes : there is no quick fix for managing #diabetes . While people work hard every day to reduce risk to their health, they must be further supported by healthcare systems. Learn more: eudf.org/our-work/recom…
#WorldDiabetesDay

Dr Grazia Dell’Agnello of LillyPad EU is our fourth presenter for today’s webinar.

In her presentation, Dr Dell’Agnello focuses on how the care pathway for people living #dementia & #Alzheimer ’s disease is continuing to evolve in light of new diagnostics & emerging treatments.

Proud to be a part of ADI’s event discussing how education and access to diagnostics and treatment can give a better future for people living with Alzheimer’s disease. It’s time to act! Check out ADI’s World Alzheimer’s Report: e.lilly/3R42ScN #Alzheimers #Dementia

When it comes to innovation, Europe is losing ground to strong global competitors. Our 🆕 report identifies 7️⃣ recommendations to increase 🇪🇺Europe’s #attractiveness as a centre for #innovation and manufacturing. Read more: bit.ly/3WzWv4S
#WeWontRest

As plans to revise #EUPharmaStrategy are under scrutiny 🇨🇿 has a crucial role to play during its EU Presidency to ensure strong & predictable intellectual property rights are in place to retain & attract investment. e.lilly/3faLI0k EFPIA AIFP EU2022_CZ

Of all new medical discoveries between 2014-2018, only 22% originated in Europe vs. 48% in 🇺🇸. #EUPharmaStrategy is the opportunity to revive innovation in Europe and turn the trend. e.lilly/3xFkHZK EFPIA Internal Market, Industry, Entrepreneurship & SMEs EuropaBio Pernille Weiss Susana Solís

Accessing new medicines can take from 133 days in 🇩🇪 to over 899 days in 🇷🇴. It’s high time to address the equity & speed of access to innovative medicines across Europe. Here’s how: e.lilly/3yhGFBV EFPIA Nathalie Moll EU One Health

As plans to revise #EUPharmaStrategy are under scrutiny 🇨🇿 has a crucial role to play during its EU Presidency in helping speed up patient access to innovative medicines across central & eastern Europe. Read more: e.lilly/3faLI0k EFPIA AIFP EU2022_CZ

To tackle the challenge of obesity, stakeholders must come together to discuss policy solutions. Healthy lifestyle is key for prevention, but so is a long-term holistic approach to treatment for those already living with #obesity . Read our policy position: e.lilly/3DHVjF5

#BehindTheScenesWithDiabetes : #diabetes is a disease that changes your life, but it doesn’t define you. If managed correctly, it can be controlled and #WeWontRest in our efforts to improve diagnosis and management. Learn more: bit.ly/2YY0VER
#WorldDiabetesDay

Our pipeline review identifies areas where we can work with other stakeholders to make Europe a global leader in medical innovation while ensuring that patients have access to innovative treatments. Read more: bit.ly/3SyaTZ4
#WeWontRest

Intellectual property spurs on researchers and companies to pursue new medicines by providing a framework that helps manage the risks, costs and time involved in developing them #IPMakesItHappen

Intellectual property supported decades of research and innovation, instrumental in delivering the vaccines and medicines to tackle the COVID-19 pandemic #IPMakesItHappen